S1131 Disease Outcomes in Patients With Inflammatory Bowel Disease and Concurrent Hidradenitis Suppurativa: A Nationwide Cohort Study

Katherine Shepherd,Ethan M. Cohen,Joshua Kirkpatrick,Alyssa Lorenze,Zach Kovach,Jennifer Hadam-Veverka
DOI: https://doi.org/10.14309/01.ajg.0001033892.17471.d6
2024-10-26
The American Journal of Gastroenterology
Abstract:Hidradenitis suppurativa (HS) is an inflammatory skin condition defined by debilitating skin lesions that form in areas with high volumes of apocrine glands, with the most common areas being the axillary, inguinal, and anogenital regions. Inflammatory bowel disease (IBD), consisting of Ulcerative colitis (UC) and Crohn's disease (CD), is a well-known inflammatory disorder of the bowel with well-documented extraintestinal manifestations. Studies have proposed a link between HS and IBD due to the inflammatory nature of both conditions, and while TNF-alpha inhibitors are an effective treatment of both diseases, data on the outcomes of IBD in this population is limited. We aim to perform the largest retrospective cohort study to date in this population, looking at the IBD outcomes of concurrent HS and IBD.
gastroenterology & hepatology
What problem does this paper attempt to address?